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Background: Reducing healthcare-associated infection (HCAI) is a UK national priority.
Multiple national and regional interventions aimed at reduction have been implemented in
National Health Service acute hospitals, but assessment of their effectiveness is meth-
odologically challenging.
Aim: To assess the effectiveness of national and regional interventions undertaken be-
tween 2004 and 2008 on rates of meticillin-resistant Staphylococcus aureus (MRSA) and
meticillin-sensitive Staphylococcus aureus (MSSA) bacteraemia within acute hospitals in
the East Midlands, using interrupted time-series analysis.
Methods: We used segmented regression to compare rates of MRSA and MSSA bacteraemia
in the pre-intervention, implementation, and post-intervention phases for combined
intervention packages in eight acute hospitals.
Findings: Most of the change in MSSA and MRSA rates occurred during the implementa-
tion phase. During this phase, there were significant downward trends in MRSA rates for
seven of eight acute hospital groups; in four, this was a steeper quarter-on-quarter
decline compared with the pre-intervention phase, and, in one, an upward trend in
the pre-intervention phase was reversed. Regarding MSSA, there was a significant posi-
tive effect in four hospital groups: one upward trend during the pre-intervention phase
was reversed, two upward trends plateaued, and in one hospital group an indeterminate
trend decreased significantly. However, there were significant increasing trends in
quarterly MSSA rates in four hospital groups during the implementation or post-
intervention periods.blic Health England, East Midlands.
lth England, 6th Floor, 5 St Philips Place, Birmingham B3 2PW, UK. Tel.: þ44 (0)344 2253560.
(S. Newitt).
by Elsevier Ltd on behalf of the Healthcare Infection Society. This is an open access article under the
ns.org/licenses/by-nc-nd/4.0/).
S. Newitt et al. / Journal of Hospital Infection 90 (2015) 28e37 29Conclusion: The impact of interventions varied by hospital group but the overall results
suggest that national and regional campaigns had a beneficial impact on MRSA and MSSA
bacteraemia within the East Midlands.
Crown Copyright ª 2015 Published by Elsevier Ltd on behalf of the Healthcare Infection
Society. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The prevalence of healthcare-associated infections (HCAIs)
was 6.4% in English National Health Service (NHS) hospitals
during 2011 with estimated treatment costs of approximately
£1 billion per year.1,2 Substantial resources have been
devoted towards decreasing the incidence of HCAI in the UK,
including, since 2004, the national campaigns: ‘Saving Lives’,
‘Cleanyourhands’, ‘Clean Safe Care’ and ‘Deep Clean Pro-
gramme’; and regional initiatives such as ‘Hand in Hand’
(2007) in the East Midlands region. These campaigns involved
hand hygiene, high-impact patient-level interventions, and
improved infection control and awareness (Supplementary
Table I).
The evaluation of HCAI interventions has generally been
constrained by methodological shortcomings in dealing with
multiple, often overlapping interventions and a lack of con-
trol sites for national interventions. Nevertheless, it is
important that interventions, particularly those that require
substantial resources, are evaluated using robust methods.
This study used interrupted time-series analysis to assess the
impact of national and regional HCAI interventions on rates
of meticillin-resistant Staphylococcus aureus (MRSA) and
meticillin-sensitive Staphylococcus aureus (MSSA) bacter-
aemia in NHS acute hospitals in the East Midlands. NHS acute
hospital services are managed by ‘acute trusts’, organiza-
tions that each deliver services to a defined geographical
area through one or more acute hospitals. Interrupted time-
series analysis is recognized as the strongest quasi-
experimental design to evaluate longitudinal effects of an
intervention.3Methods
Data sources
Anonymized quarterly counts of MRSA bacteraemia (both
hospital- and community-apportioned) from April 2001 to
March 2011 for the eight acute NHS trusts (hereafter called
‘trusts’) in the East Midlands were obtained from mandatory
data sets from Public Health England (known during 2004‒2013
as the Health Protection Agency, and before 2004 as the Public
Health Laboratory Service). Mandatory reporting of MSSA bac-
teraemia only began in January 2011; therefore numbers of
MSSA cases were calculated by subtracting the number of
‘blood culture MRSA-positive samples’ in quarterly mandatory
laboratory returns from total ‘blood culture Staphylococcus
aureus-positive samples’. Bacteraemia counts were converted
into time-series of MRSA and MSSA incidence rates per 100,000
bed-days using reported average bed-day activity.4 Ethical
approval was not required as this analysis used only aggregate,
anonymized data.Intervention data
Information on the HCAI interventions implemented in each
acute trust and their start dates had been collected previously
using detailed questionnaires with trust staff (Supplementary
Figure 1).5 These start dates were used in this study rather
than official campaign roll-out dates because actual imple-
mentation of national campaigns varied within individual trusts
due to local practicalities or involvement in pilot studies.
Where discrepant dates were identified which could not be
resolved, the earliest start date of the campaign was used to
ensure that the earliest possible implementation was
captured. The five interventions covered in the study are
detailed in Supplementary Table I.Statistical analysis
The various campaigns were implemented simultaneously or
very close together in many trusts, making it difficult to isolate
and identify the individual effects of specific campaigns.
Therefore, campaigns were evaluated together as a composite
intervention package. As in previous analyses, we defined an
‘implementation phase’ spanning the start date of the first
intervention to the start date of the last (fifth) intervention.3,6
Three trusts either did not implement or did not know the start
date for the intervention ‘Clean Safe Care’, hence only four
interventions were included in the analysis for these trusts. For
the segmented regression analysis, each time-series was split
into three segments: a ‘pre-intervention phase’, an ‘imple-
mentation phase’ and a ‘post-intervention phase’. Segmented
regression models were applied to each hospital group for MRSA
and MSSA bacteraemia separately, assessing changes in the
level and the trend of each segment compared with the
segment immediately beforehand. We used non-automated
backward elimination using the likelihood ratio test at a sig-
nificance level of P < 0.05 to remove non-significant parame-
ters and build a parsimonious model.3 An example showing the
fitted model for trust A is shown in Supplementary Figure 2.
Eachmodel was checked for the presence of autocorrelation by
visual inspection of the autocorrelation function of the model
residuals, and conducting a Portmanteau test using a signifi-
cance level of P < 0.05. There was no evidence of seasonal
autocorrelation in the model residuals. Given the relatively
short time-series and limited power to detect autocorrelation,
a sensitivity analysis was conducted using Prais‒Winsten
regression for all models to include an ‘AR(1)’ term in the
model a priori to account for non-seasonal autocorrelation.
This had no appreciable effect on the results, suggesting that
any autocorrelation was appropriately accounted for; there-
fore these data are not presented here (but are available on
request). All analyses were carried out using Stata version 11.2
(Stata Corp., College Station, TX, USA).
Table I
Final segmented regression models for MRSA rates in the eight hospital trusts in the East Midlands, UKa
Trust Mean
cases
per quarter
Pre-intervention
phase
Implementation phase Post-intervention phase Interpretation
Pre
intervention
Post
intervention
Trend in the
pre-intervention
phase
Immediate
change in level
compared to
pre-intervention
phase
Change in trend
compared to
pre-intervention
phase
Trend in the
implementation
phase
Immediate
change in level
compared to
implementation
phase
Change in trend
compared to
implementation
phase
Trend in
the post-
intervention
phase
Trust
A
N ¼ 4 N ¼ 2 7.81 1.09 1.09 1.07 Immediate
increase in level
of MRSA rates at
start of
implementation,
but significant
decreasing trend
during
implementation.
(2.62 to 13.00) (1.60 to 0.57) (1.60 to 0.57) (0.19 to 1.95)
P ¼ 0.004 P < 0.001 P < 0.001 P ¼ 0.018
Trust
B
N ¼ 10 N ¼ 4 0.39 0.39 0.39 Significant
decreasing trend
found during
implementation
and maintained
post
implementation.
(0.55 to 0.22) (0.55 to 0.22) (e0.55 to e0.22)
P < 0.001 P < 0.001 P < 0.001
Trust
C
N ¼ 5 N ¼ 2 5.18 0.58 0.58 0.58 Increase in
level of MRSA
rates at start of
implementation
but significant
decreasing trend
during and
maintained post
implementation.
(0.4 to 9.96) (0.83 to 0.34) (0.83 to 0.34) (e0.83 to e0.34)
P ¼ 0.034 P < 0.001 P < 0.001 P < 0.001
Trust
D
N ¼ 6 N ¼ 3 0.37 0.37 0.37 Significant
decreasing trend
found during
implementation
and maintained
post
implementation.
(0.55 to 0.19) (0.55 to 0.19) (e0.55 to e0.19)
P < 0.001 P < 0.001 P < 0.001
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Trust
E
N ¼ 31 N ¼ 7 0.62 0.62 0.62 Stable long-term
downward trend
with no significant
changes.
(e0.71 to e0.53) (0.71 to 0.53) (0.71 to 0.53)
P < 0.001 P < 0.001 P < 0.001
Trust
F
N ¼ 15 N ¼ 5 4.95 1.26 1.26 Immediate
decrease in level
of MRSA rates at
start of
implementation
and a significant
decreasing trend
found post
implementation.
(7.01 to 2.90) (1.51 to 1.01) (1.51 to 1.01)
P < 0.001 P < 0.001 P < 0.001
Trust
G
N ¼ 19 N ¼ 6 0.76 1.36 0.60 0.60 Significant
reversal of
upward trend
during
implementation,
decreasing trend
maintained post
implementation.
(0.31 to 1.49) (2.26 to 0.46) (0.85 to 0.34) (e0.85 to e0.34)
P ¼ 0.041 P ¼ 0.004 P < 0.001 P < 0.001
Trust
H
N ¼ 34 N ¼ 6 0.59 0.59 0.59 Stable long-term
downward trend
with no significant
changes.
(0.67 to e0.51) (0.67 to e0.51) (e0.67 to e0.51)
P < 0.001 P < 0.001 P < 0.001
MRSA, meticillin-resistant Staphylococcus aureus.
a Values in parentheses are 95% confidence intervals. Only parameters significant in the most parsimonious models have been presented, as non-significant components were removed from
the final models. All statistics relate to MRSA cases per 100,000 bed-days. The models for trusts A, F, and G were estimated using Prais‒Winsten regression to include a term for AR(1)
autocorrelation.
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Table II
Results of the final segmented regression models for MSSA rates in the eight trusts in the East Midlandsa
Trust Mean cases per
quarter
Pre-intervention
phase
Implementation
phase
Post-intervention
phase
Interpretation
Pre
intervention
Post
intervention
Trend in
the pre-
intervention
phase
Immediate
change in
level
compared
to pre-
intervention
phase
Change in trend
compared to
pre-intervention
phase
Trend in the
implementation
phase
Immediate
change in level
compared to
implementation
phase
Change in trend
compared to
implementation
phase
Trend in
the
post-
intervention
phase
Trust
A
N ¼ 18 N ¼ 13 0.65 0.65 0.65 Significant
decreasing trend
found during
implementation and
maintained post
implementation.
(1.04 to 0.25) (1.04 to 0.25) (1.04 to 0.25)
P ¼ 0.002 P ¼ 0.002 P ¼ 0.002
Trust
B
N ¼ 27 N ¼ 30 1.68 3.40 1.73 4.77 3.04 Significant
increasing
trend during
implementation but
significant
decreasing
trend post
implementation.
(2.81 to 0.54) (1.60 to 5.20) (0.85 to 2.6) (7.37 to 2.17) (5.03 to 1.06)
P ¼ 0.005 P < 0.001 P < 0.001 P ¼ 0.001 P ¼ 0.004
Trust
C
N ¼ 8 N ¼ 11 2.05 2.12 Significant upward
trend in pre-
implementation
phase reduced
during
implementation
phase.
(0.41 to 3.70) (3.96 to 0.28)
P ¼ 0.016 P ¼ 0.003
Trust
D
N ¼ 11 N ¼ 14 1.04 1.04 23.1 1.04 Immediate decrease
in level of MSSA
post implementation
but no change
to trend.
(0.39 to 1.70) (0.39 to 1.70) (37.0 to 9.14) (0.39 to 1.70)
P < 0.003 P < 0.003 P ¼ 0.002 P < 0.003
Trust
E
N ¼ 50 N ¼ 47 Stable long-term
flat trend with no
significant
changes.
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Trust
F
N ¼ 25 N ¼ 17 1.19 1.99 0.80 0.80 Significant reversal
of upward trend
during
implementation,
decreasing trend
maintained post
implementation.
(0.21 to 2.17) (3.23 to 0.76) (1.18 to 0.42) (1.18 to 0.42)
P ¼ 0.019 P ¼ 0.002 P < 0.001 P < 0.001
Trust
G
N ¼ 27 N ¼ 30 1.06 1.30 0.98 0.74 Significant decrease
in the trend
during
implementation,
but actual trend not
significant or
maintained.
(0.51 to 1.60) (2.04 to 0.55) (0.17 to 1.79) (0.13 to 1.36)
P < 0.001 P ¼ 0.001 P ¼ 0.019 P ¼ 0.019
Trust
H
N ¼ 47 N ¼ 31 0.39 0.39 13.31 0.39 Immediate decrease
in level of MSSA post
implementation.
Significant
increasing
trend during
implementation
and maintained post
implementation.
(0.07 to 0.71) (0.07 to 0.71) (19.44 to 7.17) (0.07 to 0.71)
P ¼ 0.020 P ¼ 0.020 P < 0.001 P ¼ 0.020
MSSA, meticillin-susceptible Staphylococcus aureus.
a Values in parentheses are 95% confidence intervals. Only parameters significant in the most parsimonious models have been presented, as non-significant components were removed from
the final models. All statistics relate to MSSA cases per 100,000 bed-days.
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Figure 1. Meticillin-resistant Staphylococcus aureus (MRSA) rates per 100,000 bed-days for each trust in the East Midlands (solid line) with
the fitted final segmented regression model (dashed line).
S. Newitt et al. / Journal of Hospital Infection 90 (2015) 28e3734Results
The results of the final segmented regression models for
each trust can be seen in Tables I and II, and in Figures 1 and 2.
MRSA
In the pre-intervention phase, quarterly rates of MRSA
significantly decreased over time in two trusts (E and H),
significantly increased in one (G), and there was no significant
trend in the remainder (N ¼ 5).
During the implementation phase, there was a significant
downward trend in MRSA rates in seven trusts (A‒E, G, H). In
four trusts (A‒C, D) the rate of decline of MRSA infection during
the implementation phase was significantly steeper than the
rate of decline in the pre-intervention phase. Additionally, in
trust G the significant upward trend observed in the pre-
intervention phase was reversed, giving a significant
decreasing trend of 0.60 fewer cases per 100,000 bed-days per
quarter [95% confidence interval (CI): 0.85 to 0.34]. Two
trusts (A, C) saw an immediate significant increase in the levelof the quarterly incidence rate of MRSA between the last
quarter in the pre-intervention phase and the first quarter in
the implementation phase, and trust F had a significant im-
mediate decrease of 4.95 cases per 100,000 bed-days (95%
CI: 7.01 to 2.90).
For six trusts (B‒E, G, H) the downward trend in MRSA rates
in the implementation phase continued at the same rate
during the post-intervention phase, but in trust F there was a
significantly steeper rate of decline during this phase of 1.26
cases per 100,000 bed-days per quarter (95% CI: 1.51
to 1.01). In trust A, the declining trend during the imple-
mentation phase levelled off post-intervention (significant
change in trend 1.07 cases per 100,000 bed-days per quarter;
95% CI: 0.19 e 1.95).
MSSA
In the pre-intervention phase, quarterly rates of MSSA
significantly increased over time in four trusts (C, D, F, G),
significantly decreased in one (B), and there was no significant
trend in the remaining three.
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Figure 1. (continued).
S. Newitt et al. / Journal of Hospital Infection 90 (2015) 28e37 35During the implementation phase there was a significant
downward trend in MSSA rates in only two trusts; in trust F,
the significant upward trend in the pre-intervention phase
was reversed, giving a decreasing quarterly trend of ‒0.8
cases per 100,000 bed-days, per quarter (95% CI: ‒1.18 to ‒
0.42) and for trust A there was a rate of decrease of ‒0.65
cases per 100,000 bed-days, per quarter (95% CI: ‒1.04 to ‒
0.25). In two trusts (C and G), significant changes in the trend
meant that the upward trend in the pre-intervention phase
reverted to a constant level during the implementation
phase. There was a significant increasing quarterly trend in
MSSA cases for three trusts (B, D, H) during the imple-
mentation phase. In trust E there were no significant trends
or immediate changes in MSSA rates across the three phases.
There was an immediate significant decrease in the quarterly
rates of MSSA infection, between the last quarter of the
implementation phase and the first quarter of the post-
intervention phase in trusts D and H, of 23.1 cases (95% CI:
‒37.0 to ‒9.14) and 13.31 cases (95% CI: ‒19.44 to ‒7.17) per
100,000 bed-days, respectively.
During the post-intervention phase there was a significant
downward trend in MSSA cases for three trusts (A, B, F) with the
significant increasing trend in quarterly MSSA rates in trust B
reversing to a decreasing trend of 3.04 cases per 100,000 bed-
days, per quarter (95% CI: ‒5.03 to ‒1.06). There was a sig-
nificant increasing trend in MSSA cases for three trusts (D, G, H)
but there was no significant change in the trend from the
implementation phase for trusts C and E.Discussion
During the implementation phase there was a downward
trend in MRSA rates for seven trusts; in four trusts this was a
steeper quarter-on-quarter decline compared to the pre-
intervention phase, and in one other the upward trend in the
pre-intervention phase was reversed. In the post-intervention
phase, the downward trend in rates continued for six trusts,
with one trust experiencing a steeper quarterly decline in MRSA
rates compared with the implementation phase. These findings
suggest that the intervention package was effective in reducing
MRSA bacteraemia in most trusts. The results for MSSA rates
were more variable. There was a change in the trend of MSSA
rates in six trusts during the implementation phase compared
to the pre-intervention phase. For four trusts this was a posi-
tive effect with the upward trend in MSSA rates during the pre-
intervention phase either reverting to constant or starting todecline. However, for some trusts the trend in quarterly MSSA
rates increased during the implementation and post-
intervention phase.
Due to the interventions being analysed as a composite
intervention package, we cannot disentangle the effects of
individual components. Existing literature suggests that a
decrease in infection rates would be expected due to hand
hygiene interventions and this is consistent with the national
evaluation of the ‘Cleanyourhands’ campaign.6 In addition to
the major national interventions, the targets set by govern-
ment during the study period may also be relevant: in 2004
trusts were set a target of a 50% reduction in MRSA bacter-
aemia by 2008; and in 2006 Trust Chief Executives were
required to take personal responsibility for their MRSA data.7
Both requirements undoubtedly had an effect on MRSA
rates, with many interventions implemented or intensified in
response. Therefore, other interventions may have contrib-
uted to our findings, such as universal MRSA screening,
hydrogen peroxide decontamination, and the introduction of
chlorhexidine decolonization.8 Although we are not aware of
any specific issues, we acknowledge that changes in case mix,
laboratory testing methodology or antimicrobial prescribing
practices such as the use of quinolones, which are indepen-
dently associated with changes in MRSA rates, could have
been confounding factors. It has been suggested that the
reduction in MRSA rates nationally is due to changes in strain
types with rates already decreasing before the introduction of
interventions.9,10 However, a reducing trend in MRSA rates in
the pre-implementation phase was only observed in two trusts
in the East Midlands, making it easier to infer that the
observed changes were attributable to interventions during
this time period. Both of these trusts also had a high initial
rate of MRSA bacteraemia (>20 per 100,000 population) sug-
gesting that the starting rate may impact the rate of reduc-
tion. As expected, we observed variation in the effect of
interventions by trust. These may be due to differences in
compliance and the enthusiasm with which they were intro-
duced locally. Two trusts saw an immediate significant in-
crease in the MRSA rate at the beginning of the
implementation phase, which is difficult to explain and may
be due to unmeasured confounding.
The interventions might be expected to have similar effects
on both MRSA and MSSA, but national MSSA rates have not
decreased at the same rate as MRSA.11 The limited literature on
the effect of interventions on MSSA rates has shown little or
no impact, which is in keeping with our findings.6,12,13 No
distinction was made between trust- and community-
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Figure 2. Meticillin-susceptible Staphylococcus aureus (MSSA) rates per 100,000 bed-days for each trust in the East Midlands (solid lines)
with the fitted final segmented regression model (dashed lines).
S. Newitt et al. / Journal of Hospital Infection 90 (2015) 28e3736apportioned infection within this study, as these data were only
available from 2005, by which time, interventions had already
been implemented. Although national data show that most
MRSA bacteraemia was designated as hospital-acquired during
the time period,w70% of MSSA bacteraemia was thought to be
community-acquired.11 Trust-based interventions would
therefore have limited effect on community-apportioned
infection and may explain the variable success seen against
MSSA. This study did not collect strain typing information, so it
is unknown whether changes in or the prominence of certain
strains may have played a part in the limited reduction of MSSA.
The national and international importance of HCAI and the
resources invested in its prevention mean that evaluation of
interventions is essential. This has been problematic, because
standard research methodologies such as cluster-randomized
trials of specific interventions have seldom been attempted.
Reviews of previous local evaluations have highlighted meth-
odological weaknesses in study design, making it difficult to
draw conclusions and make comparisons across studies.14,15 To
ensure robust and comparable research into HCAI in-
terventions, we used interrupted time-series analysis, whichhas been recognized as an appropriate study design for hospital
epidemiology.16 When used appropriately, this methodology
can help to make sense of complex data, where multiple in-
terventions have been applied near-simultaneously and where
randomization cannot be applied for ethical or logistical rea-
sons. This is the first time to our knowledge that this method-
ology has been used to assess national and regional campaigns
as a composite ‘intervention package’ on the effect of HCAI
rates in multiple acute trusts. In some trusts it appeared that
infection rates started to decline only partway through the
intervention period rather than at the start. However, the
methodology used here adheres to quality criteria for inter-
rupted time-series studies and all intervention points were
specified a priori to limit the number of statistical tests
undertaken.17
The strengths of this study include the use of a mandatory
data set, where data have been recorded consistently over
time and acute trusts were analysed individually rather than
for the region as a whole, avoiding ecological fallacy. However,
inclusion of a specific regional campaign challenges general-
izability of the findings to other trusts or regions in England;
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Figure 2. (continued).
S. Newitt et al. / Journal of Hospital Infection 90 (2015) 28e37 37and the intervention start dates provided from staff may be
subject to recall bias. The impact of the interventions we
studied varied by trust, but the overall results suggest that
national and regional campaigns have played an important role
in reducing MRSA bacteraemia rates within East Midlands acute
hospitals. The data are somewhat less convincing for MSSA,
where other community-related factors may have complicated
the epidemiological situation.
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